CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

Autor: Gong, Jiahao1,2 (AUTHOR), Han, Guoyong1,2 (AUTHOR), Chen, Zhiqiang1,2 (AUTHOR), Zhang, Yinqi1,2 (AUTHOR), Xu, Bin3 (AUTHOR), Xu, Chao1,2 (AUTHOR), Gao, Wen4 (AUTHOR) gaowen@jsph.org.cn, Wu, Jindao1,2 (AUTHOR) wujindao@njmu.edu.cn
Zdroj: Journal of Translational Medicine. 5/30/2024, Vol. 22, p1-20. 20p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje